HBsAg titers in the different phases of hepatitis B infection in Syrian patients

Journal of Clinical Virology

Volumn 53, Issue 1, 2012, Pages 60-64

  Antaki, Nabil ^a   Zeidane, Negib ^b   Alhaj, Nezameldine ^c   Hadad, Milad ^d   Baroudi, Osama ^e   Antaki, Fadi ^f   AbouHarb, Raed ^c   Haffar, Samir ^c   Abdelwahab, Jarir ^g   AliDeeb, Sawsan ^e   Asaad, Fouad ^h   Aljesri, Ali ⁱ   Doghman, Daad ^j   Aaraj, Riad ^k   Ibrahim, Nazir ^l   Ali, Ayman ^j   Assil, Marwan ⁱ   Sabah, Houda ^e   Katranji, Nizar ^c   Kebbewar, Kamel ^a  

^a Saint Louis Hospital   (Syrian Arab Republic)

^b Department of Gastroenterology   (Syrian Arab Republic)

^c Department of Medical Laboratory   (Syrian Arab Republic)

^d Ibn Nafis Hospital   (Syrian Arab Republic)

^e Damascus Hospital   (Syrian Arab Republic)

^f WAYNE STATE UNIVERSITY   (United States)

^g Alforat Hospital   (Syrian Arab Republic)

^h Squelbiye National Hospital   (Syrian Arab Republic)

ⁱ Aleppo University Hospital   (Syrian Arab Republic)

^j Department of Gastroenterology   (Syrian Arab Republic)

^k Department of Gastroenterology   (Syrian Arab Republic)

^l SYRIAN PRIVATE UNIVERSITY   (Syrian Arab Republic)

more..

Author keywords

Chronic hepatitis B; HBV DNA; Quantitative HBsAg

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS E ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA DETERMINATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SYRIAN ARAB REPUBLIC; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNE TOLERANCE; INFANT; MALE; MIDDLE AGED; SYRIA; VIRUS REPLICATION; YOUNG ADULT;

EID: 83355173908     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.10.004     Document Type: Article

References (23)

1. Dienstag J.L. Hepatitis B virus infection. N Engl J Med 2008, 359:1486-1500.
2. Wong V.W., Wong G.L., Chim A.M., Choi P.C., Chan A.W., Tsang S.W., et al. Surrogate endpoints and long-term outcome in patients with chronic hepatitis B. Clin Gastroenterol Hepatol 2009, 7:1113-1120.
3. Sung J.J., Tsoi K.K., Li K.C., Wong V.W., Chan H.L. Meta-analysis: treatment of hepatitis B infection reduces risk of hepato-cellular carcinoma. Aliment Pharmacol Ther 2008, 28:1067-1077.
4. European Association for the Study of the Liver EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009, 50:227-242.
5. Moucari R., Mackiewicz V., Lada O., Ripault M.P., Castelnau C., Martinot-Peignoux M., et al. Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg negative patients. Hepatology 2009, 49:1151-1157.
6. Brunetto M.R., Moriconi F., Bonino F., Lau G.K., Farci P., Yurdaydin C., et al. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology 2009, 49:1141-1150.
7. Lau G.K., Marcellin P., Brunetto M., Piratvisuth T., Kapprell H.P., Button P. On-treatment HBsAg decline during peginterferon alfa-2a (40kDa)±lamivudine in patients with HBeAg-positive CHB as a potential predictor of durable off-treatment response. Hepatology 2008, 48:714A.
8. Borgniet O., Parvaz P., Bouix C., Chevallier P., Trépo C., André P., et al. Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B. J Med Virol 2009, 81:1336-1342.
9. Wursthorn K., Jung M., Manns M.P., Lopez P., Wedemeyer H., Naoumov N. Kinetics of HBsAg decline in HBeAg+ chronic hepatitis B patients with 3 years of telbivudine treatment during the Globe study. J Hepatol 2009, 50:S9.
10. Fattovich G., Bortolotti F., Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008, 48:335-352.
11. Yim H.J., Lok A.S. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006, 43:S173-S181.
12. Thompson A., Locarnini S., Visvanathan K. The natural history and the staging of chronic hepatitis B: time for reevaluation of the virus-host relationship based on molecular virology and immunopathogenesis considerations?. Gastroenterology 2007, 133:1031-1035.
13. ® HBsAg II screening assay: results of a feasibility study. Hepatology 2008, 48:726A.
14. Wursthorn K., Jaroszewicz J., Zacher B.J., Darnedde M., Raupach R., Mederacke I., et al. Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum. J Clin Virol 2011, 50(April (4)):292-296.
15. Louisirirotchanakul S., Khupulsup K., Akraekthalin S., Chan K.P., Saw S., Aw T.C., et al. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays. J Med Virol 2010, 82(May (5)):755-762.
16. Antaki N., Haffar S., Alideeb S., Asaad F., Abouharb R., Zeidane N., et al. High prevalence of HBV genotype D in Syria and the clinical characteristics of hepatitis B e antigen-negative chronic hepatitis B. Epidemiol Infect 2010, 138(January (1)):40-44.
17. Blumberg B.S., Alter H.J., Visnich S.A. " New" antigen in leukemia sera. J Am Med Assoc 1965, 191:541-546.
18. Brunetto M.R. A new role for an old marker, HBsAg. J Hepatol 2010, 52:475-477.
19. Lu L., Ye D.W., Wang Y.D., Kwok A.Y.K., Wong A., Yueng H., et al. Relationshipbetween HBV cccDNA and HBsAg levels is associated with HBeAg status of chronic hepatitis B patients. J Hepatol 2009, 50:S209.
20. Jaroszewicz J., Calle Serrano B., Wursthorn K., Deterding K., Schlue J., Raupach R., et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 2010, 52:514-522.
21. Nguyen T., Thompson A.J., Bowden S., Croagh C., Bell S., Desmond P.V., et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 2010, 52:508-513.
22. Kim Y.J., Cho H.C., Choi M.S., Lee J.H., Koh K.C., Yoo B.C., et al. The change of the quantitative HBsAg level during the natural course of chronic hepatitis B. Liver Intern 2011, 52:817-823.
23. Chan H.L., Wong W.W., Wong G.L., Tse C.H., Chan H.Y., Sung J.J. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology 2010, 52:1232-1241.